Scientific Reports (Nov 2022)

Development of a deep learning method for improving diagnostic accuracy for uterine sarcoma cases

  • Yusuke Toyohara,
  • Kenbun Sone,
  • Katsuhiko Noda,
  • Kaname Yoshida,
  • Ryo Kurokawa,
  • Tomoya Tanishima,
  • Shimpei Kato,
  • Shohei Inui,
  • Yudai Nakai,
  • Masanori Ishida,
  • Wataru Gonoi,
  • Saki Tanimoto,
  • Yu Takahashi,
  • Futaba Inoue,
  • Asako Kukita,
  • Yoshiko Kawata,
  • Ayumi Taguchi,
  • Akiko Furusawa,
  • Yuichiro Miyamoto,
  • Takehiro Tsukazaki,
  • Michihiro Tanikawa,
  • Takayuki Iriyama,
  • Mayuyo Mori-Uchino,
  • Tetsushi Tsuruga,
  • Katsutoshi Oda,
  • Toshiharu Yasugi,
  • Kimihiro Takechi,
  • Osamu Abe,
  • Yutaka Osuga

DOI
https://doi.org/10.1038/s41598-022-23064-5
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 11

Abstract

Read online

Abstract Uterine sarcomas have very poor prognoses and are sometimes difficult to distinguish from uterine leiomyomas on preoperative examinations. Herein, we investigated whether deep neural network (DNN) models can improve the accuracy of preoperative MRI-based diagnosis in patients with uterine sarcomas. Fifteen sequences of MRI for patients (uterine sarcoma group: n = 63; uterine leiomyoma: n = 200) were used to train the models. Six radiologists (three specialists, three practitioners) interpreted the same images for validation. The most important individual sequences for diagnosis were axial T2-weighted imaging (T2WI), sagittal T2WI, and diffusion-weighted imaging. These sequences also represented the most accurate combination (accuracy: 91.3%), achieving diagnostic ability comparable to that of specialists (accuracy: 88.3%) and superior to that of practitioners (accuracy: 80.1%). Moreover, radiologists’ diagnostic accuracy improved when provided with DNN results (specialists: 89.6%; practitioners: 92.3%). Our DNN models are valuable to improve diagnostic accuracy, especially in filling the gap of clinical skills between interpreters. This method can be a universal model for the use of deep learning in the diagnostic imaging of rare tumors.